TriSalus Life Sciences Inc
TLSI
Get informed when a big investor buys or sells
+ FollowMarket Cap$129.27M
Close$
$-8.19
357.6% downside
Current Fair Value
357.6% downsideOvervalued by 357.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $129.27 Million |
|---|---|
| Enterprise Value | $107.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.84 |
| Beta | 0.56 |
| Outstanding Shares | 51,539,682 |
Return
| Return on Equity | -451.13% |
|---|---|
| Return on Assets | -81.40% |
| Return on Invested Capital | -46.84% |
Valuation & Multiples
| P/E Ratio | -6.43 |
|---|---|
| PEG | 5.65 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.39 |
| Enterprise Value to EBIT | -3.87 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 2.69 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.16
Average shareholder expectationRevenue Estimate
$10.44 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$10.79 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.44%▲ 17.95% |
|---|---|
| Total Invested | $83.28M▲ 4.58% |
| Investors Holding | 85▲ 21.00% |
ESG Score
No data